Optimization of time interval for the measurement of plasma lipids for cardiovascular disease risk assessment.

Maureen L SampsonAnna WolskaRafael ZubiránJustine ColeMarcelo AmarAlan T Remaley

Published in: Expert review of molecular diagnostics (2024)

Testing patients for lipids who have a higher baseline risk more often could identify high-risk patients sooner, allowing for earlier and more effective therapeutic intervention.

Keyphrases

end stage renal disease
cardiovascular disease
risk assessment
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
heavy metals
cardiovascular risk factors
human health